Ignite Creation Date:
2024-05-05 @ 5:03 PM
Last Modification Date:
2024-10-26 @ 9:27 AM
Study NCT ID:
NCT00371345
Status:
COMPLETED
Last Update Posted:
2011-04-26
First Post:
2006-09-01
Brief Title:
Study of Dasatinib BMS-354825 in Patients With Advanced EstrogenProgesterone Receptor-positive ERPR or Her2Neu-positive Her2NeuBreast Cancer
Sponsor:
Bristol-Myers Squibb
Organization:
Bristol-Myers Squibb
Key Dates - Follows AllAPIJSON File Order
Start Date:
2006-12
Start Date Type:
None
Primary Completion Date:
2009-03
Primary Completion Date Type:
ACTUAL
Completion Date:
2009-05
Completion Date Type:
ACTUAL
First Submit Date:
2006-09-01
First Submit QC Date:
September 1 2006
Study First Post Date:
2006-09-04
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
2010-11-05
Results First Post Date Type:
ESTIMATED
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2011-04-21
Last Update Post Date:
2011-04-26
Last Update Post Date Type:
ESTIMATED